Pancreatic Cancer Research

ResearcherEmory UniversityNo recent work listed

Natalyn Nicole Hawk

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5080508830. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 trial · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. A Phase 1 Study of Stereotactic Body Radiation Therapy Dose Escalation for Borderline Resectable Pancreatic Cancer After Modified FOLFIRINOX (NCT01446458). First author DOI 10.1016/j.ijrobp.2016.05.010↗
  2. Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e31829e2006↗

Trials 1

  1. Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer Principal investigator NCT01446458↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jerome Carl Landry · 2 shared papers, 2013–2016 · strength 0.09
  2. David A. Kooby · 2 shared papers, 2013–2016 · strength 0.09
  3. Shishir Kumar Maithel · 2 shared papers, 2013–2016 · strength 0.09
  4. Bassel F. El‐Rayes · 2 shared papers, 2013–2016 · strength 0.09
  5. Juan Manuel Sarmiento · 1 shared paper, 2016 · strength 0.05
  6. Walid Labib Shaib · 1 shared paper, 2016 · strength 0.05
  7. Hemchandra Mahaseth · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.